Total no. of subjects | 31 |
Boys/girls | 14/17 |
Age at followup, yrs, mean (range) | 16.4 (6–25) |
Disease duration at followup, yrs, mean (range) | 8.8 (2.5–22) |
Disease features at initial measurement, n (%) | |
Active systemic features | 29 (94) |
Active arthritis | 30 (97) |
Disease features at followup, n (%) | |
Active systemic features | 7 (23) |
Active arthritis | 17 (55) |
Medications at followup (no. patients) | |
NSAID (total users) | 26 |
NSAID only | 9 |
Any immunomodulatory medication | 17 |
Prednisone | 8 |
Methotrexate | 9 |
Cyclosporine | 2 |
TNF inhibitors | 3 |
None | 5 |
NSAID: nonsteroidal antiinflammatory drug.